Azim Premji Foundation, the National Centre for Biological Sciences (NCBS-TIFR), and the Institute for Stem Cell Science and Regenerative Medicine (inStem) have partnered together to augment testing infrastructure and facilities to deal with the COVID- 19 pandemic.

These organisations have collaborated to conduct research into new and innovative methods for testing for the SARS-CoV-2 virus, a PTI reports said.

The collaboration would enable free-of-cost testing for COVID-19 to a large number of people from disadvantaged and marginalised communities, using NCBS-TIFR and inStem’s high-capacity technical capabilities and skilled scientific personnel, an Azim Premji Foundation statement said.

The institutions will also actively research innovative methods of testing that can potentially help enhance the country’s capacity and speed of COVID-19 testing considerably, it said.

NCBS-TIFR and In-Stem are testing centres approved by their respective Departments, Atomic Energy (DAE) and Biotechnology (DBT), as per the guidelines of the Indian Council for Medical Research (ICMR), it was stated.

NCBS-TIFR and inStem are institutions working on research in the frontier areas of biology.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.